Long COVID news: where to find reliable updates

Keeping up with long COVID news is particularly difficult. The field is moving quickly, new research is published constantly, and coverage is often either sensationalised or shaped by broader political attitudes to COVID-19.

This page is not a feed of the latest headlines. It is a guide to where reliable news lives, and how to read it without burning through energy you do not have to spare.

Most health news coverage of long COVID is poor. Stories tend to overclaim on the basis of small preliminary studies. Some present private clinics’ promotional material as research news, or frame the condition through a political lens rather than a clinical one.

Before giving a story your attention, it is worth checking a few things.

Who funded the research?
Reliable studies are usually funded by universities, major research charities, or public research councils. Be wary of work funded only by a clinic or company that sells the treatment being promoted.

Has the research been peer-reviewed and published?
Press releases about findings that have not yet been peer-reviewed should be read as provisional. The same goes for work only presented at a conference.

Is it a single study, or part of a broader pattern?
Individual studies often contradict each other. Reliable reporting puts new findings in the context of what else is known.

How is the story framed?
Responsible coverage talks about findings, associations, possible mechanisms, or early evidence. Be cautious of the language of breakthroughs, miracles, and cures, and equally cautious of coverage claiming the condition is overstated or not real.

You do not need to read specialist journals to stay informed. A small number of established organisations summarise new research in accessible language and apply appropriate caution to their reporting.

Patient-Led Research Collaborative
A patient-run research group, often the earliest to spot patterns that later reach academic literature.

Long Covid SOS
A UK patient-led advocacy group tracking policy developments, research funding, and NHS provision.

Long Covid Kids
A UK charity covering children and young people, an area that receives particularly little mainstream coverage.

Our resources page lists the full set, including research foundations and support communities.

Even good reporting can make a study sound more conclusive than it is.

A single study is not proof
Findings need to be replicated, ideally by other teams in other populations, before they can be considered reliable.

Correlation is not causation
A study finding that people with long COVID differ from healthy controls does not mean that difference caused the illness.

Preliminary is the most important word in research news
Early findings are the starting point of a long process. Most do not hold up.

Long COVID research is published at a higher rate than either ME/CFS or fibromyalgia research. That is good for the field, but it means the proportion of findings that will not survive replication is particularly high. A calmer reading of a single study is usually a more accurate one.

Several areas of ongoing advocacy are worth following through the organisations above.

Research funding
Public funding has been significant since 2020, but it is uneven across countries. It has faced criticism in some settings for prioritising rehabilitation studies over biomedical mechanism research.

NHS clinic provision
Provision has narrowed sharply since the national programme was stood down in 2024, and patient organisations are pushing for more consistent access. Our managing long COVID guide covers what this means in practice.

Recognition in benefits systems
Long COVID is increasingly recognised in UK disability and benefits assessments, but the process remains inconsistent. The organisations above track developments and provide guidance.

Progress on these fronts is slower than people with long COVID need it to be.